Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial
- 1 December 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 147 (6) , 1218-1226
- https://doi.org/10.1046/j.1365-2133.2002.05059.x
Abstract
Summary Background Botulinum toxin type A (BTX‐A) has been shown to be a safe and effective treatment for primary focal hyperhidrosis. However, the effect of BTX‐A therapy on quality of life (QOL...Keywords
This publication has 16 references indexed in Scilit:
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlledBMJ, 2001
- Botulinum A toxin improves life quality in severe primary focal hyperhidrosisEuropean Journal of Neurology, 2001
- Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)New England Journal of Medicine, 2001
- Treatment of Axillary Hyperhidrosis:Dermatologic Surgery, 2000
- Are We Paying a High Price for Surgical Sympathectomy? A Systematic Literature Review of Late ComplicationsThe Journal of Pain, 2000
- The Illness Intrusiveness Rating Scale: A measure of severity in individuals with hyperhidrosisQuality of Life Research, 1999
- TREATMENT OF HYPERHIDROSISDermatologic Clinics, 1998
- Die subkutane Schweißdrüsensaugkürettage in Tumeszenzlokalanästhesie bei Hyperhidrosis axillarisDie Dermatologie, 1997
- Endoscopic Thoracic Sympathectomy for Primary Hyperhidrosis of the Upper Limbs A Critical Analysis and Long-Term Results of 480 OperationsAnnals of Surgery, 1994
- Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosisBritish Journal of Dermatology, 1993